A Three-Part Phase I Study to Determine the Potential Drug Interaction Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil in Healthy Subjects

Trial Profile

A Three-Part Phase I Study to Determine the Potential Drug Interaction Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs ACH 4471 (Primary) ; Fexofenadine; Midazolam; Mycophenolate mofetil
  • Indications Glomerulonephritis; Haemolytic uraemic syndrome; Paroxysmal nocturnal haemoglobinuria
  • Focus Pharmacokinetics
  • Sponsors Achillion Pharmaceuticals
  • Most Recent Events

    • 15 Jun 2017 Status changed from recruiting to completed.
    • 08 May 2017 Status changed from not yet recruiting to recruiting.
    • 13 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top